Variations of C3 and C4 Before and During Pregnancy in Systemic Lupus Erythematosus : Association With Disease Flares and Obstetric Outcomes
Copyright © 2023 by the Journal of Rheumatology..
OBJECTIVE: To analyze complement level variations in systemic lupus erythematosus (SLE) pregnancies, focusing on disease flares and obstetric complications.
METHODS: SLE pregnancies prospectively followed by multidisciplinary teams from 1987 to 2018 in 2 Italian rheumatology centers were retrospectively analyzed. As reference, pregnancy-modified ranges of normal levels of C3 and C4 were derived from 175 pregnancies from the general obstetric population (GOP), as previously described by our group.
RESULTS: Two hundred forty-six pregnancies in 172 patients with SLE were analyzed. Eighty-nine percent were live births. Thirty-five flares were recorded in 30 pregnancies (12.2%) and obstetric complications occurred in 47 pregnancies (19.1%) including 27 pregnancy losses, 11 severely preterm births (2 resulting in perinatal death), and 15 hypertensive disorders. C3 and C4 levels were higher in the GOP than in patients with SLE, at any time point. C3 and C4 levels progressively increased during pregnancy in both GOP and SLE pregnancies without flare and obstetric complications, whereas this physiological increase was not observed in pregnancies with flares or obstetric complications. A significantly higher frequency of low C4 was found in pregnancies with flares (at preconception and in each trimester) and preterm births (at preconception). In multivariate analysis, low C4 at preconception was associated with flares (odds ratio 13.81, 95% CI 3.10-61.43, P < 0.001).
CONCLUSION: Low C4 at preconception was found to be an independent risk factor for SLE flare during pregnancy. Not only C3 and C4 levels but also their variations should be observed, as their failure to increase can be useful to predict risk of complications and suggest closer monitoring.
| Errataetall: |
CommentIn: J Rheumatol. 2023 Oct;50(10):1203-1204. - PMID 37582557 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:50 |
|---|---|
| Enthalten in: |
The Journal of rheumatology - 50(2023), 10 vom: 01. Okt., Seite 1296-1301 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Crisafulli, Francesca [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Complement C3 |
|---|
| Anmerkungen: |
Date Completed 05.10.2023 Date Revised 25.10.2023 published: Print-Electronic CommentIn: J Rheumatol. 2023 Oct;50(10):1203-1204. - PMID 37582557 Citation Status MEDLINE |
|---|
| doi: |
10.3899/jrheum.2022-1135 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM356306720 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM356306720 | ||
| 003 | DE-627 | ||
| 005 | 20231226070201.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3899/jrheum.2022-1135 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1187.xml |
| 035 | |a (DE-627)NLM356306720 | ||
| 035 | |a (NLM)37127323 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Crisafulli, Francesca |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Variations of C3 and C4 Before and During Pregnancy in Systemic Lupus Erythematosus |b Association With Disease Flares and Obstetric Outcomes |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.10.2023 | ||
| 500 | |a Date Revised 25.10.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: J Rheumatol. 2023 Oct;50(10):1203-1204. - PMID 37582557 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 by the Journal of Rheumatology. | ||
| 520 | |a OBJECTIVE: To analyze complement level variations in systemic lupus erythematosus (SLE) pregnancies, focusing on disease flares and obstetric complications | ||
| 520 | |a METHODS: SLE pregnancies prospectively followed by multidisciplinary teams from 1987 to 2018 in 2 Italian rheumatology centers were retrospectively analyzed. As reference, pregnancy-modified ranges of normal levels of C3 and C4 were derived from 175 pregnancies from the general obstetric population (GOP), as previously described by our group | ||
| 520 | |a RESULTS: Two hundred forty-six pregnancies in 172 patients with SLE were analyzed. Eighty-nine percent were live births. Thirty-five flares were recorded in 30 pregnancies (12.2%) and obstetric complications occurred in 47 pregnancies (19.1%) including 27 pregnancy losses, 11 severely preterm births (2 resulting in perinatal death), and 15 hypertensive disorders. C3 and C4 levels were higher in the GOP than in patients with SLE, at any time point. C3 and C4 levels progressively increased during pregnancy in both GOP and SLE pregnancies without flare and obstetric complications, whereas this physiological increase was not observed in pregnancies with flares or obstetric complications. A significantly higher frequency of low C4 was found in pregnancies with flares (at preconception and in each trimester) and preterm births (at preconception). In multivariate analysis, low C4 at preconception was associated with flares (odds ratio 13.81, 95% CI 3.10-61.43, P < 0.001) | ||
| 520 | |a CONCLUSION: Low C4 at preconception was found to be an independent risk factor for SLE flare during pregnancy. Not only C3 and C4 levels but also their variations should be observed, as their failure to increase can be useful to predict risk of complications and suggest closer monitoring | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a complement C3 | |
| 650 | 4 | |a complement C4 | |
| 650 | 4 | |a pregnancy | |
| 650 | 4 | |a systemic lupus erythematosus | |
| 650 | 7 | |a Complement C3 |2 NLM | |
| 650 | 7 | |a Complement C4 |2 NLM | |
| 700 | 1 | |a Andreoli, Laura |e verfasserin |4 aut | |
| 700 | 1 | |a Zucchi, Dina |e verfasserin |4 aut | |
| 700 | 1 | |a Reggia, Rossella |e verfasserin |4 aut | |
| 700 | 1 | |a Gerardi, Maria C |e verfasserin |4 aut | |
| 700 | 1 | |a Lini, Daniele |e verfasserin |4 aut | |
| 700 | 1 | |a Tani, Chiara |e verfasserin |4 aut | |
| 700 | 1 | |a Zatti, Sonia |e verfasserin |4 aut | |
| 700 | 1 | |a Franceschini, Franco |e verfasserin |4 aut | |
| 700 | 1 | |a Mosca, Marta |e verfasserin |4 aut | |
| 700 | 1 | |a Tincani, Angela |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of rheumatology |d 1983 |g 50(2023), 10 vom: 01. Okt., Seite 1296-1301 |w (DE-627)NLM000019593 |x 1499-2752 |7 nnns |
| 773 | 1 | 8 | |g volume:50 |g year:2023 |g number:10 |g day:01 |g month:10 |g pages:1296-1301 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3899/jrheum.2022-1135 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 50 |j 2023 |e 10 |b 01 |c 10 |h 1296-1301 | ||